216 related articles for article (PubMed ID: 34315494)
1. Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy.
Hu H; Yang W; Liang Z; Zhou Z; Song Q; Liu W; Deng X; Zhu J; Xing X; Zhong B; Wang B; Wang S; Shao Z; Zhang Y
J Nanobiotechnology; 2021 Jul; 19(1):221. PubMed ID: 34315494
[TBL] [Abstract][Full Text] [Related]
2. Lycorine Induces Apoptosis and G1 Phase Arrest Through ROS/p38 MAPK Signaling Pathway in Human Osteosarcoma Cells In Vitro and In Vivo.
Ning L; Wan S; Jie Z; Xie Z; Li X; Pan X; Wan X; Chen W; Huang H; Wang J; Qin A; Fan S; Zhao X
Spine (Phila Pa 1976); 2020 Feb; 45(3):E126-E139. PubMed ID: 31464976
[TBL] [Abstract][Full Text] [Related]
3. Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
Shang H; Jang X; Shi L; Ma Y
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22882. PubMed ID: 34558146
[TBL] [Abstract][Full Text] [Related]
4. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
5. A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer.
Jiang Y; Guo Z; Fang J; Wang B; Lin Z; Chen ZS; Chen Y; Zhang N; Yang X; Gao W
Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110224. PubMed ID: 31761194
[TBL] [Abstract][Full Text] [Related]
6. Synergism through combination of chemotherapy and oxidative stress-induced autophagy in A549 lung cancer cells using redox-responsive nanohybrids: a new strategy for cancer therapy.
Lu HY; Chang YJ; Fan NC; Wang LS; Lai NC; Yang CM; Wu LC; Ho JA
Biomaterials; 2015 Feb; 42():30-41. PubMed ID: 25542791
[TBL] [Abstract][Full Text] [Related]
7. Folic Acid-Conjugated Gold Nanostars for Computed Tomography Imaging and Photothermal/Radiation Combined Therapy.
Hu P; Hou X; Yu X; Wei X; Li Y; Yang D; Jiang X
ACS Appl Bio Mater; 2021 Jun; 4(6):4862-4871. PubMed ID: 35007035
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeting graphene oxide nanocomposites for fluorescence imaging-guided synergistic phototherapy of drug-resistant osteosarcoma.
Zeng WN; Yu QP; Wang D; Liu JL; Yang QJ; Zhou ZK; Zeng YP
J Nanobiotechnology; 2021 Mar; 19(1):79. PubMed ID: 33740998
[TBL] [Abstract][Full Text] [Related]
9. Construction of Fluorescein Isothiocyanate-Labeled MSNs/PEG/Lycorine/Antibody as Drug Carrier for Targeting Prostate Cancer Cells.
Liu X; Kang J; Wang H; Huang T; Li C
J Nanosci Nanotechnol; 2018 Jul; 18(7):4471-4477. PubMed ID: 29442621
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis.
Gao L; Feng Y; Ge C; Xu X; Wang S; Li X; Zhang K; Wang C; Dai F; Xie S
Phytomedicine; 2021 May; 85():153530. PubMed ID: 33761445
[TBL] [Abstract][Full Text] [Related]
11. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
12. Lycorine ameliorates isoproterenol-induced cardiac dysfunction mainly via inhibiting inflammation, fibrosis, oxidative stress and apoptosis.
Wu J; Fu Y; Wu YX; Wu ZX; Wang ZH; Li P
Bioengineered; 2021 Dec; 12(1):5583-5594. PubMed ID: 34515620
[TBL] [Abstract][Full Text] [Related]
13. A Janus upconverting nanoplatform with biodegradability for glutathione depletion, near-infrared light induced photodynamic therapy and accelerated excretion.
Zhou H; Li Q; Cheng X; Zhang C; Sun J; Du L; Cao J; Liu Y; Huang P
J Mater Chem B; 2020 Oct; 8(40):9251-9257. PubMed ID: 32929430
[TBL] [Abstract][Full Text] [Related]
14. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
15. Inorganic photosensitizer coupled Gd-based upconversion luminescent nanocomposites for in vivo magnetic resonance imaging and near-infrared-responsive photodynamic therapy in cancers.
Zhang L; Zeng L; Pan Y; Luo S; Ren W; Gong A; Ma X; Liang H; Lu G; Wu A
Biomaterials; 2015 Mar; 44():82-90. PubMed ID: 25617128
[TBL] [Abstract][Full Text] [Related]
16. Polydopamine-Functionalized Graphene Oxide Loaded with Gold Nanostars and Doxorubicin for Combined Photothermal and Chemotherapy of Metastatic Breast Cancer.
Wang F; Sun Q; Feng B; Xu Z; Zhang J; Xu J; Lu L; Yu H; Wang M; Li Y; Zhang W
Adv Healthc Mater; 2016 Sep; 5(17):2227-36. PubMed ID: 27377242
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous polydopamine-coated hydroxyapatite nano-composites for ROS-triggered nitric oxide-enhanced photothermal therapy of osteosarcoma.
Wang YC; Dai HL; Li ZH; Meng ZY; Xiao Y; Zhao Z
J Mater Chem B; 2021 Sep; 9(36):7401-7408. PubMed ID: 34551050
[TBL] [Abstract][Full Text] [Related]
18. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
19. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma.
Li X; Xu P; Wang C; Xu N; Xu A; Xu Y; Sadahira T; Araki M; Wada K; Matsuura E; Watanabe M; Zheng J; Sun P; Huang P; Nasu Y; Liu C
Oncotarget; 2017 Mar; 8(13):21177-21186. PubMed ID: 28416753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
